Radiology AI startup Qure.ai has been recognized among Time Magazine's 'Most Influential Companies in the World' for 2025.
Key Details
- 1Qure.ai is an India-based radiology artificial intelligence startup founded in 2016.
- 2It has deployed imaging AI solutions in over 100 countries.
- 3The company claims its tools interpret X-ray, CT, and ultrasound images in under a minute.
- 4Qure.ai holds 18 U.S. FDA clearances, including a leading number for lung cancer AI, with three new approvals in 2024.
- 5Qure.ai recently closed a $65 million Series D financing round.
- 6Time Magazine selected Qure.ai for its impact, innovation, and success in global healthcare.
Why It Matters
Qure.ai's international recognition and significant regulatory clearances highlight the growing acceptance and deployment of radiology AI solutions worldwide. The company's achievements set a benchmark for startups aspiring to combine clinical efficacy with broad accessibility.
Source
Radiology Business
Related News
•HealthExec
US Executive Order and HHS Strategy Set AI Policy Directions for Healthcare
The White House executive order and new HHS strategy shift US policy towards unified AI standards and expanded adoption in healthcare.
•AuntMinnie
Debate at RSNA 2025 Examines If AI Is Ready for Autonomous Chest X-ray Reads
Experts at RSNA 2025 debated whether AI is ready for fully autonomous interpretation of chest x-rays, concluding that while technical progress is evident, significant challenges remain.
•Radiology Business
a2z Radiology Raises $5M, Lands FDA Clearance for Multi-Condition CT AI
Boston-based a2z Radiology raised $4.5M and earned FDA clearance for its Unified Triage AI solution for abdominal and pelvic CT scans.